Try it
Pharmacology · Antivirals: CMV drugs
Sample itemA transplant recipient with CMV retinitis is treated with ganciclovir and develops a neutrophil count of 0.6 thousand per microlitre. Another patient on a different anti-CMV drug develops rising creatinine and electrolyte disturbances. Which pair fits?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Ganciclovir with neutropenia, and foscarnet with nephrotoxicity
Ganciclovir causes dose-limiting bone marrow suppression, while foscarnet is nephrotoxic and causes hypocalcaemia and other electrolyte disorders. Cidofovir is also nephrotoxic and is given with probenecid and hydration.
Option by option
A. Oseltamivir with neutropenia, and foscarnet with hepatotoxicity
Oseltamivir is not myelotoxic.
B. Ganciclovir with neutropenia, and foscarnet with nephrotoxicity (correct)
Correct. Each pairing is characteristic.
C. Ganciclovir with nephrotoxicity, and foscarnet with neutropenia
The toxicities are reversed in this option.
D. Cidofovir with neutropenia, and aciclovir with ototoxicity
Cidofovir is nephrotoxic, not mainly myelosuppressive.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?